An international drug firm tried to “scupper” publicly funded trials into an eye medicine that was cheaper and just as effective as the one used by the NHS, the country’s leading medical journal has alleged.
from - Health & Families RSS Feed http://ind.pn/1Hk9SJ4
via Health and Families
No comments:
Post a Comment